Abdominal pain in the emergency department: the importance of history taking for common clinical presentations

David J Holland and Michael J Holland
Med J Aust 2019; 210 (11): . || doi: 10.5694/mja2.50202
Published online: 17 June 2019

A 26‐year‐old man presented to the emergency department (ED) overnight with severe and disabling abdominal pain. On initial assessment, he described sudden onset sharp pain in the right iliac fossa 6 hours earlier, with subsequent generalisation across the abdomen and the development of nausea and vomiting, subjective fevers, profuse diaphoresis and pleuritic chest pain. On examination, there was general abdominal discomfort without rebound tenderness; clinical observations and the remainder of the examination were unremarkable. Basic investigations demonstrated a normal full blood count, electrolytes and liver function tests. The history and examination were not typical of an acute abdomen, appendicitis or cholecystitis. The patient provided a past medical history notable for gastro‐oesophageal reflux disease and a diagnosis of irritable bowel syndrome following a normal colonoscopy with a gastroenterologist. Intravenous analgesia was provided and resulted in symptomatic improvement.

  • 1 Sunshine Coast University Hospital, Sunshine Coast, QLD
  • 2 University of Queensland, Brisbane, QLD
  • 3 Griffith Health, Griffith University, Gold Coast, QLD


Competing interests:

No relevant disclosures.

  • 1. Masatlioglu S, Dulundu E, Gogus F, et al. The frequency of familial Mediterranean fever in an emergency unit. Clin Exp Rheumatol 2011; 29 (Suppl): S44–S46.
  • 2. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial mediterranean fever. Arthritis Rheum 1997; 40: 1879–1885.
  • 3. Federici S, Sormani MP, Ozen S, et al. Evidence‐based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis 2015; 74: 799–805.
  • 4. Giancane G, Ter Haar NM, Wulffraat N, et al. Evidence‐based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis 2015; 74: 635–641.
  • 5. Booty MG, Chae JJ, Masters SL, et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 2009; 60: 1851–1861.
  • 6. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473–483.
  • 7. Wu B, Xu T, Li Y, Yin X. Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database Syst Rev 2018; (10): CD010893.
  • 8. Padeh S, Yackov B. Familial Mediterranean fever. Curr Opin Rheumatol 2016; 28: 523–529.
  • 9. Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 2016; 75: 644–651.
  • 10. Twig G, Livneh A, Vivante A, et al. Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents. Ann Rheum Dis 2014; 73: 704–709.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.